Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...
Could Alzheimer’s treatment drugs be the next big investor opportunity after obesity pills?
The search for effective Alzheimer’s treatments is emerging as a promising market, capturing the attention of major ...
New dementia tool predicts when symptoms will start: ‘Would you want to know?’
Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...
WVTF2h
The promise of focused ultrasound in treating Alzheimer's disease
There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...
Rolling Out6d
5 ways this cancer drug could revolutionize Alzheimer’s treatment
Groundbreaking research reveals how a cancer drug could restore brain function in early Alzheimer's patients by targeting glucose metabolism. Here's what you need to know.
Rolling Out5d
Dopamine’s surprising breakthrough in Alzheimer’s treatment
Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...
Daily Mail5d
Hopes new drug likened to 'exercise in a pill' will deal a major blow against Alzheimer's
People suffering from the early onset of Alzheimer's disease are being given access to a revolutionary drug that's being hailed as a potential cure. The drug, Xanamem, works by blocking the ...
STAT11d
Axsome to send Alzheimer’s disease drug to FDA, despite mixed Phase 3 results
Axsome Therapeutics said it would submit its Alzheimer’s disease treatment for FDA approval despite mixed results from two ...
China Medical System （00867）Obtained New Drug ZUNVEYL for the Treatment of Mild-to-Moderate Dementia of the Alzheimer’s Type
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Why Alzheimer’s Scientists Are Re-thinking the Amyloid Hypothesis
For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...
STAT3d
Using lab-grown human mini-brains, scientists find links between head trauma, herpes, and Alzheimer’s
Research published Tuesday is the first to connect the dots between a common herpes virus, head injury, and Alzheimer's.